GeminIQ Website Logo

Viewing KBLB free

Subscribe for full history, 90+ metrics, screener, watchlist...

Kraig Biocraft Laboratories, Inc.

KBLB

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
332210112233
Assets Current
Assets Current
432210112233
Inventory Net
000000000000
Prepaid Expense Current
000000000000
Deposits Assets Current
-----------0
Property Plant And Equipment Net
000000000000
Investment In Physical Commodities
010011111100
Operating Lease Right Of Use Asset
000000000000
Security Deposit
000000000000
Assets
443221222334
Liabilities And Stockhold…
Liabilities Current
Liabilities Current
1111101010101099999
Operating Lease Liability Current
000000000000
Loans Payable Current
--------0000
Liabilities Noncurrent
Operating Lease Liability Noncurrent
000000000000
Liabilities
1111111010101099999
Additional Paid In Capital
131312121212121212111111
Stockholders Equity
Stockholders Equity
-7-7-8-8-8-9-8-7-7-6-6-5
Retained Earnings Accumulated Deficit
-59-58-57-56-54-54-53-52-52-50-50-48
Liabilities And Stockholders Equity
443221222334
Investment Owned At Cost
00000000000-
Preferred Stock No Par Value
000000000000
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Shares Issued
----3152,158------

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-14.29%-21.43%-35.71%---------
20250.00%-11.11%-11.11%0.00%12.50%12.50%0.00%0.00%-11.11%36.36%18.18%0.00%
20248.33%16.67%-16.67%-18.18%-18.18%-18.18%22.22%11.11%0.00%12.50%12.50%12.50%
2023----25.00%-25.00%-25.00%0.00%33.33%33.33%-10.00%10.00%50.00%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.33
0.28
0.18
0.16
0.08
0.05
0.08
0.13
0.17
0.23
0.29
0.35
Quick Ratio
0.31
0.27
0.17
0.15
0.08
0.04
0.07
0.13
0.17
0.23
0.29
0.35
Working Capital
-7.33M
-7.67M
-8.58M
-8.54M
-9.19M
-9.37M
-8.87M
-8.10M
-7.61M
-6.90M
-6.31M
-5.57M
Leverage & Debt
Debt to Equity
-1.63
-1.53
-1.32
-1.30
-1.19
-1.15
-1.18
-1.28
-1.32
-1.44
-1.57
-1.73
Interest Coverage TTM
-6.27
-6.25
-5.91
-5.99
-4.28
-5.94
-5.81
-4.69
-4.81
-4.19
-5.40
-15.91
Debt Ratio
2.58
2.90
4.12
4.38
6.32
7.50
6.41
4.63
4.14
3.25
2.77
2.38
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.04
0.04
0.03
0.02
Per Share Metrics
Diluted EPS TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Free Cash Flow Per Share TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-
-
-
-11,301.04%
-5,846.74%
-3,260.94%
-1,944.92%
-2,386.65%
-2,549.67%
Net Profit Margin TTM
-
-
-
-
-
-
-12,493.34%
-6,382.74%
-3,630.11%
-2,242.24%
-2,765.43%
-3,484.74%
Growth Metrics
Net Revenue Growth (1Y)
-
-
-100.00%
-100.00%
-100.00%
-100.00%
-75.17%
-20.29%
308.29%
3,003.68%
-
-
Net Income Growth (1Y)
58.92%
13.60%
6.60%
-4.76%
-34.53%
17.51%
12.18%
46.00%
36.90%
-11.64%
-21.14%
-34.67%
EPS Growth (1Y)
49.92%
8.46%
4.48%
-7.43%
-35.10%
17.16%
11.62%
45.30%
36.24%
-12.17%
-25.63%
-38.26%
Valuation Metrics
P/E TTM
-26.76
-30.26
-26.32
-26.07
-32.09
-26.85
-27.49
-24.14
-33.85
-34.95
-13.64
-11.69
P/B TTM
-16.45
-16.99
-11.92
-12.08
-9.89
-10.97
-11.47
-12.70
-19.36
-16.64
-7.24
-6.20
P/S TTM
-
-
-
-
-
-
3,435.04
1,540.56
1,228.76
783.70
377.19
407.36
Market Cap
111.03M
120.00M
95.35M
96.14M
83.80M
93.73M
93.45M
93.45M
134.99M
103.84M
41.32M
31.00M
Enterprise Value
107.64M
117.10M
93.56M
94.58M
83.01M
93.33M
92.78M
92.26M
133.47M
101.81M
38.81M
28.16M
Calculated Values
Free Cash Flow TTM
-2.08M
-1.90M
-1.79M
-1.86M
-1.72M
-1.78M
-1.84M
-1.65M
-1.58M
-1.34M
-1.25M
-1.36M
Net Debt
-3.39M
-2.89M
-1.79M
-1.57M
-785.46K
-397.00K
-673.26K
-1.19M
-1.52M
-2.03M
-2.52M
-2.84M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2022-07-20Sale
Owner: Thompson, Kimberly Kraig
Title: CEO & CFO
Shares: 120,000
Price/Share: -
Value: -
Shares Owned: 201,587,924
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2022-07-18Sale
Owner: Thompson, Kimberly Kraig
Title: CEO & CFO
Shares: 79,900
Price/Share: -
Value: -
Shares Owned: 201,757,924
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2022-07-13Sale
Owner: Thompson, Kimberly Kraig
Title: CEO & CFO
Shares: 11,500
Price/Share: -
Value: -
Shares Owned: 201,887,824
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2022-07-11Sale
Owner: Thompson, Kimberly Kraig
Title: CEO & CFO
Shares: 100,000
Price/Share: -
Value: -
Shares Owned: 201,899,324
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2022-07-08Sale
Owner: Thompson, Kimberly Kraig
Title: CEO & CFO
Shares: 40,000
Price/Share: -
Value: -
Shares Owned: 201,999,324
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
0.01%
Inst. Shares: 62,952
Shares Outstanding: 1,090,869,198

Kraig Biocraft Laboratories, Inc. (KBLB) — SEC Financial Statements & Analysis

Kraig Biocraft Laboratories, Inc. (KBLB) is a plastic material, synth resin/rubber, cellulos (no glass) company, incorporated in WY. Kraig Biocraft Laboratories, Inc. trades on OTC as: KBLB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Kraig Biocraft Laboratories, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.63x, a Price-to-Sales (P/S) ratio of 3435.04x (TTM), a Price-to-Book (P/B) ratio of -16.45x (TTM), at a market cap of $111.03M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
-1.63x
P/S TTM
3435.04x
P/B TTM
-16.45x
Market Cap
$111.03M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Kraig Biocraft Laboratories, Inc. in?

Kraig Biocraft Laboratories, Inc. (KBLB) operates in the Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) industry.

What is KBLB's market cap?

Kraig Biocraft Laboratories, Inc. (KBLB) has a market capitalization of $111.03M as of 2026-06-30.

What exchange does KBLB trade on?

Kraig Biocraft Laboratories, Inc. (KBLB) trades on the OTC.

Where is Kraig Biocraft Laboratories, Inc. incorporated?

Kraig Biocraft Laboratories, Inc. is incorporated in WY.

Companies in Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)

Wall Street's data.
Main Street's price.